Company Filing History:
2 out of 174 
1 out of 832,891 Years Active: 2002-2006
Title: Xinqiang Li: Innovator in HIV Research
Introduction
Xinqiang Li, a prominent inventor based in San Diego, California, has made significant strides in the field of pharmaceutical innovations. With a focus on HIV treatments, he has been awarded three patents that reflect his dedication to advancing medical science. His groundbreaking work has the potential to change the landscape of HIV therapies.
Latest Patents
Among his latest innovations are patents related to HIV integrase inhibitors and pharmaceutical compositions. Specifically, his work on beta-carboline hydroxamic acid compounds, represented by formula (I), showcases methods for inhibiting or modulating the activity of the HIV integrase enzyme. These compounds could play a crucial role in treating HIV integrase-mediated diseases and conditions, offering new hope for effective therapies.
Career Highlights
Throughout his career, Xinqiang Li has made valuable contributions while working for Agouron Pharmaceuticals, Inc. His role at this company has allowed him to apply his expertise and focus on innovative drug development, particularly in relation to HIV.
Collaborations
Xinqiang has collaborated with distinguished peers such as Atsuo Kuki and Michael Bruno Plewe. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in developing effective treatments.
Conclusion
In conclusion, Xinqiang Li is a vital contributor to the field of HIV research, with his patented inventions showcasing innovative approaches to combating this persistent virus. His work continues to inspire and pave the way for future advancements in both pharmaceutical compositions and methods that can ultimately improve the lives of those affected by HIV.